Article

Gender differences in the plasma profiles of PCSK9, soluble LDLR, total cholesterol, and triglycerides in patients with colorectal cancer liver metastases: diagnostic and prognostic implications

2026-01-30

Abstract excerpt

<title>Abstract</title> <p> <bold>Background.</bold> Proprotein convertase subtilisin/kexin-type 9 (PCSK9) and soluble low-density lipoprotein receptor (sLDLR) are blood proteins that down regulate LDLR-mediated uptake of plasma LDL-cholesterol into cells. In healthy subjects, the plasma level of PCSK9 and sLDLR strongly correlates with that of total cholesterol (TC) and triglycerides (TG), respectively. Since...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b32d5df-21a1-5597-af9a-19c77929cca5
DOI: 10.21203/rs.3.rs-7420891/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gender differences in the plasma profiles of PCSK9, soluble LDLR, total cholesterol, and triglycerides in patients with colorectal cancer liver metastases: diagnostic and prognostic implicationsDOI 10.21203/rs.3.rs-7420891/v1Read

Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function.Semantic proximity Read

PCSK9 Exhibits Novel Nuclear Localization in LSEC and Its Targeting with Bioinspired Nanoparticles Reduces Colorectal Liver MetastasisSemantic proximity Read

PCSK9: a key modulator of cardiovascular health.Semantic proximity Read

Differential Expression of Serum-Derived Exosomal miRNAs in Colorectal Cancer Patients with Liver MetastasisSemantic proximity Read

Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced SurvivalSemantic proximity Read

[PCSK9: Structure and function. PCSK9 and low-density lipoprotein receptor. Mutations and their effects].Semantic proximity Read

Proteomic Profiling and Biomarker Discovery in Colorectal Liver MetastasesSemantic proximity Read

The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.Semantic proximity Read

Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.Semantic proximity Read

PCSK9 is a critical regulator of the innate immune response and septic shock outcome.Semantic proximity Read

Revealing the Role of High-Density Lipoprotein in Colorectal Cancer.Semantic proximity Read

Plasma PCSK9 levels correlate with cholesterol in men but not in women.Semantic proximity Read